Mauna Kea Technologies today announced that management will participate in the following upcoming investor conferences in January: The...
Mauna Kea Technologies to Participate at Three Upcoming Investor Conferences in January
read more
Search Results
Mauna Kea Technologies welcomes Jacquelien ten Dam to Board of Directors
Mauna Kea Technologies announced today the cooptation by the Board of Ms. Jacquelien ten Dam as an Independent Director, effective immediately....
Telix Pharmaceuticals Limited and Mauna Kea Technologies Announce the “Imaging and Robotics in Surgery (IRiS) Alliance”
The IRiS Alliance is an exclusive scientific and clinical research collaboration that combines two highly complementary technologies to deliver...
Mauna Kea Technologies announces two new publications demonstrating the efficacy, safety and accuracy of Cellvizio® for Pancreatic Cyst Evaluation
Further peer-reviewed evidence that using Cellvizio as an adjunct to the standard of care can significantly improve the speed and accuracy of...
Mauna Kea Technologies reports third quarter and first nine months of 2020 sales
Third Quarter Total Sales Increase 13% year-over-year; U.S. Sales up 7% First Nine Months Total Sales Decrease 28% year-over-year; Significant...
Mauna Kea Technologies reports full financial results for first half of 2020 and preliminary third quarter of 2020 sales
1H’20 financial results driven primarily by a 10% reduction in total operating expenses (without COGS) and a 17% reduction in net loss...
Mauna Kea Technologies to announce 2020 Half Year Results on September 22, 2020
Company to host business update conference call on Tuesday, September 22, 2020, at 6:00 PM CEST (Paris time) / 1:00 PM (New York time) Mauna...
Mauna Kea Technologies appoints Claire Biot, Ph.D. to board of directors
Mauna Kea Technologies announced today the appointment of Claire Biot, Ph.D., as an Independent Director, effective immediately. Dr Claire Biot...
Mauna Kea Technologies reports second quarter and first half of 2020 sales
First Half of 2020 total sales down 47%; U.S. sales down 19% Second Quarter total sales down 72%; U.S. sales down 47% Sufficient...
Mauna Kea Technologies announces further strengthening of financial condition by securing €4M of non-dilutive loans guaranteed by the French state (PGE)
Mauna Kea Technologies announced that it has received financing approvals from BNP Paribas and Bpifrance for a total of €4 million in...
Mauna Kea Technologies draws down the €6m second tranche of loan agreement with the European Investment Bank (EIB)
Mauna Kea Technologies announced it has drawn down the €6m second tranche of their €22.5 million loan agreement concluded on 20 June...
Mauna Kea Technologies Announces the Launch of a First in Human Study Combining Robotic Navigational Bronchoscopy and Needle-Based Confocal Laser Endomicroscopy
The Cellvizio® 100 series system with the AQ-Flex™ 19 Confocal Miniprobe™ will be used for the assessment of peripheral lung...